NCT03183232View on ClinicalTrials.gov

Safety and Efficiency of γδ T Cell Against Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2019

Conditions
Lung Cancer
Interventions
PROCEDURE

Cryosurgery or IRE surgery

Cryosurgery or IRE surgery will be used in local tumor

BIOLOGICAL

γδ T cell

γδ T cells will be used against Lung Cancer

OTHER

γδ T cells/ A Cryosurgery or IRE

Combination γδ T cell and Cryosurgery or IRE surgery will be used in Lung Cancer

Trial Locations (1)

510665

Biotherapy center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Jinan University Guangzhou

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT03183232 - Safety and Efficiency of γδ T Cell Against Lung Cancer | Biotech Hunter | Biotech Hunter